natgillin/translations-raw huggingface dataset:
Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis.
Pogosto opisani neželeni učinki (pri najmanj 1 na vsakih 100 bolnikov, vendar manj kot 1 na vsakih 10 bolnikov): žeja, dehidracija, zvišan krvni tlak, migrene, otekle bezgavke, pordelost, težave z menstruacijo, zmanjšana spolna sla, vaginalne težave, bolečine v dojkah, bolečine v modih, težave z žlezo ščitnico, pordele dlesni, suha usta, pordela ali vneta usta ali jezik, zobobol ali zobne bolezni, herpes simpleks (vročinske razjede), sprememba okusa, želodčne težave, dispepsija (zgaga), zaprtje, povečanje jeter (jetrne težave, včasih hude), vodeno blato, močenje postelje pri otrocih, vnetje sinusov, bronhitis, očesne bolečine, težave s solznimi kanalčki, konjunktivitis (“ rdeče oko ”), vznemirjenost, zaspanost, hoja v spanju, vedenjske težave, živčnost, zamašen nos ali izcedek iz nosa, kihanje, hitro dihanje, bleda ali pordela koža, podplutbe, velika občutljivost prstov na rokah in nogah na mraz, težave s
 463 Uncommonly reported side effects (at least 1 in every 1000 patients, but less than 1 in every 100 patients): bacterial infection and feeling of pins and needles.
Občasno opisani neželeni učinki (pri najmanj 1 na vsakih 1. 000 bolnikov, vendar manj kot 1 na vsakih 100 bolnikov): bakterijske okužbe, pojav parastezij.
6.
481 6.
- The active substance is recombinant interferon alfa-2b, 18 million IU/pen
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 18 milijonov i. e. / peresnik.
 464 What IntronA looks like and contents of the pack
Izgled zdravila IntronA in vsebina pakiranja
IntronA is presented as a solution for injection.
IntronA je na voljo kot raztopina za injiciranje.
IntronA, 18 million IU/pen, solution for injection:
IntronA, 18 milijonov i. e. / peresnik, raztopina za injiciranje:
- Pack of 1 pen, 12 injection needles and 12 cleansing swabs
1 peresnik, 12 injekcijskih igel in 12 čistilnih tamponov
- Pack of 2 pens, 24 injection needles and 24 cleansing swabs
2 peresnika, 24 injekcijskih igel in 24 čistilnih tamponov
- Pack of 8 pens, 96 injection needles and 96 cleansing swabs
8 peresnikov, 96 injekcijskih igel in 96 čistilnih tamponov
Norge Pb.
482 Norge Deutschland Pb.
Lietuva Kęstučio g.
483 Lietuva Kęstučio g.
 466 HOW TO SELF INJECT INTRONA
484 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
- the IntronA multidose pen;
- večodmerni peresnik zdravila IntronA;
- a needle for subcutaneous injection (provided in the packaging);
- iglo za subkutano injiciranje (priložena v pakiranju);
Use the injection needles provided in the packaging only for IntronA.
Uporabite injekcijske igle, ki so priložene v pakiranju le za IntronA.
- The push button scale tells you what dose has been set.
- Lestvica z gumbom vam pove, kakšen odmerek je nastavljen.
- The colour coding strip brown and the push button are at the bottom of the pen as it is held cap
- Rjav trak za barvno kodiranje jakosti in gumb sta na dnu peresnika, če ga držite tako, da je
up.
pokrovček peresnika na vrhu.
- The pen can only be fully capped when the triangle on the cap scale is aligned with the dosage
- Peresnik lahko do konca pokrijete s pokrovčkom le, če je trikotnik na lestvici pokrovčka
indicator on the barrel.
Zunanji pokrovček igle Pokrovček
Cap
Lestvica na Notranji pokrovčku pokrovček igle Igla Gumijasta opna Igla
Cap scale
Rezervoar
Needle Rubber membrane
Kazalnik odemerkov Telo peresnika
Reservoir
Barvna koda
Dosage indicator
Lestvica na
Pen barrel
Ščitnik
Colour coding Push button
Gumb
Push button scale
gumbu
 467 Measuring the dose of IntronA Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected.
485 Merjenje odmerka zdravila IntronA Peresnik vzemite iz hladilnika približno pol ure pred injiciranjem, da bo raztopina v njem ob injiciranju na sobni temperaturi.
Check that IntronA, solution for injection, is clear and colourless in appearance prior to use.
Pred uporabo preverite, ali je IntronA raztopina za injiciranje bistra in brezbarvna.
Gently push the injection needle onto the pen as shown in Diagram E.
Nežno potisnite injekcijsko iglo na peresnik, kot je prikazano na sliki E.
(Notice that the rear portion of the injection needle will pierce through the rubber membrane that you disinfected previously).
Zadnji del injekcijske igle bo predrl skozi gumijasto opno, ki ste jo prej dezinficirali).
carefully, bearing in mind that the injection needle will now be exposed (Diagram H).
Najprej snemite zunanji pokrovček injekcijske igle (slika G), potem pa previdno še notranjega in pri tem ne pozabite, da je injekcijska igla zdaj nezaščitena (slika H).
 468
486
ready to use.
Peresnik je pripravljen za uporabo.
Since a small amount of air may collect in the
Ker se lahko med skladiščenjem v injekcijski igli in rezervoarju nabere majhna količina zraka, morate najprej odstraniti morebitne zračne mehurčke, kar imenujemo injiciranje v zrak.
This is called performing the Air- Shot.
Držite IntronA raztopino za injiciranje v večodmernem peresniku z injekcijsko iglo navzgor.
Hold the IntronA, solution for injection, multidose pen with the injection needle point upwards.
Potrkajte po rezervoarju s prstom, da bodo morebitni zračni mehurčki splavali na vrh rezervoarja, tik pod injekcijsko iglo (slika I).
Tap the reservoir with your finger so that any air bubbles rise to the top of the reservoir, just below the injection needle (Diagram I).
Rezervoar
Hold the pen by the barrel and turn the reservoir in the direction as indicated by the arrow in Diagram J (clockwise) until you feel it click.
Držite peresnik za telo in obračajte rezervoar v smeri puščice na sliki J (t. j. v smeri urnega kazalca), dokler ne začutite klika.
Keeping the pen pointing upwards, press the push button up fully and see if a drop of IntronA, solution for injection, appears at the injection needle tip (Notice the drop at the tip of injection needle in Diagram K below).
Pritisnite na gumb do konca in poglejte, ali se na vrhu injekcijske igle pojavi kapljica IntronA raztopine za injiciranje (glejte kapljico na vrhu injekcijske igle na sliki K spodaj).
 469 Diagram K
487 Slika K
Note: some air may remain in the pen, but this is not important as you have removed the air from the injection needle and the dose will be accurate.
V peresniku lahko ostane nekaj zraka, vendar to ni pomembno, saj ste odstranili zrak iz injekcijske igle in bo odmerek torej pravilen.
Replace the IntronA, solution for injection, multidose pen cap with the ‘triangle’ opposite the dosage indicator as seen in Diagram L.
Postavite pokrovček nazaj na večodmerni peresnik IntronA raztopina za injiciranje tako, da bo trikotnik postavljen nasproti kazalnika odmerkov, kot je prikazano na sliki L.
With the other hand, turn the cap in a clockwise direction indicated by the arrow in Diagram M.
Z drugo roko obrnite pokrovček v smeri urnega kazalca, kot kaže puščica na sliki M.
You will observe the push button rising, indicating the dose set.
Videli boste, da se je pritisni gumb dvignil, kar pomeni nastavljanje odmerka.
 470 Number of “turns” and “clicks”
Število “ obratov ” in “ klikov ”
Corresponding doses (million IU) using
Ustrezen odmerek (milijoni i. e.)
IntronA, solution for injection, multidose pen 18 million IU/pen
uporabljenega zdravila IntronA, raztopina za injiciranje, večodmerni peresnik 18 milijonov i. e. / peresnik
1 full
1 polni
turn (5 clicks)
obrat (5 klikov)
6 clicks
6 klikov
7 clicks
7 klikov
8 clicks
8 klikov
9 clicks
9 klikov
2.7
488
2 full turns (10 clicks)
2 polna obrata (10 klikov)
11 clicks
11 klikov
12 clicks
12 klikov
13 clicks
13 klikov
14 clicks
14 klikov
3 full turns (15 clicks)
3 polni obrati (15 klikov)
16 clicks
16 klikov
17 clicks
17 klikov
18 clicks
18 klikov
19 clicks
19 klikov
4 full turns (20 clicks)*
4 polni obrati (20 klikov) *
*4 full turns correspond to the maximum dose to be administered in one injection.
* 4 polni obrati ustrezajo največjemu odmerku za dajanje v eni injekciji.
 471 Diagram N
Slika N
Diagram O Injecting the solution Select the injection site.
Injiciranje raztopine Izberite si mesto, kamor boste injicirali zdravilo.
Insert the needle into the pinched skin at an angle of approximately 45°.
Vbodite iglo v kožno gubo pod kotom približno 45.
Keeping the push button down, leave the injection needle in place for a few seconds to allow the IntronA, solution for injection, to distribute under the skin, then remove.
Še naprej pritiskajte na gumb in pustite injekcijsko iglo v koži nekaj sekund, da se bo lahko IntronA raztopina za injiciranje porazdelila pod kožo, potem potegnite iglo ven.
 472 Diagram Q
Slika Q
Completely unscrew the injection needle assembly using an anti-clockwise turning motion as shown in Diagram R.
490 Do konca odvijte sklop injekcijske igle, nasprotno smeri urnega kazalca, kot je prikazano na sliki R.
Then carefully lift it off the pen and discard the capped injection needle (see Diagram S).
Potem ga previdno dvignite s peresnika in zavrzite pokrito injekcijsko iglo (glejte sliko S).
Replace the pen cap with the triangle once again opposite the dosage indicator as shown in Diagram T.
Pokrovček peresnika postavite nazaj na peresnik, pri čemer naj bo trikotnik spet nasproti kazalnika odmerkov, kot je prikazano na sliki T.
Then return the pen to the refrigerator.
Vrnite peresnik v hladilnik.
IntronA 30 million IU solution for injection, multidose pen Interferon alfa-2b
IntronA 30 milijonov i. e., raztopina za injiciranje, peresnik z večimi odmerki interferon alfa- 2b
 475 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
493 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 476 Multiple myeloma:
494 Multipli mielom:
 477 Paediatric Use:
495 Uporaba pri otrocih:
 478 Uncommonly reported side effects (at least 1 in every 1000 patients, but less than 1 in every 100 patients): bacterial infection and feeling of pins and needles.
Občasno opisani neželeni učinki (pri najmanj 1 na vsakih 1. 000 bolnikov, vendar manj kot 1 na vsakih 100 bolnikov): bakterijske okužbe, pojav parastezij.
6.
497 6.
- The active substance is recombinant interferon alfa-2b, 30 million IU/pen
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 30 milijonov i. e. / peresnik.
 479 What IntronA looks like and contents of the pack
Izgled zdravila IntronA in vsebina pakiranja
IntronA, 30 million IU/pen, solution for injection:
IntronA, 30 milijonov i. e. / peresnik, raztopina za injiciranje:
Norge Pb.
498 Norge Deutschland Pb.
Lietuva Kęstučio g.
499 Lietuva Kęstučio g.
 481 HOW TO SELF INJECT INTRONA
500 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
- The colour coding strip blue and the push button are at the bottom of the pen as it is held cap
- Moder trak za barvno kodiranje jakosti in gumb sta na dnu peresnika, če ga držite tako, da je
 482 Measuring the dose of IntronA Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected.
501 Merjenje odmerka zdravila IntronA Peresnik vzemite iz hladilnika približno pol ure pred injiciranjem, da bo raztopina v njem ob injiciranju na sobni temperaturi.
carefully, bearing in mind that the injection needle will now be exposed (Diagram H).
502 Najprej snemite zunanji pokrovček injekcijske igle (slika G), potem pa previdno še notranjega in pri tem ne pozabite, da je injekcijska igla zdaj nezaščitena (slika H).
 4 84 Diagram K
Slika K
Number of “turns” and
Število “ obratov ” in “ klikov ”
IntronA, solution for injection, multidose pen 30 million IU/pen:
uporabljenega zdravila IntronA, raztopina za injiciranje, večodmerni peresnik 30 milijonov i. e. / peresnik:
1 full turn (5 clicks)
obrat (5 klikov)
3.5
504
* 4 full turns correspond to the maximum dose to be administered in one injection.
* 4 polni obrati ustrezajo največjemu odmerku za dajanje v eni injekciji.
 486 Diagram N
Slika N
 487 Diagram Q
Slika Q
Completely unscrew the injection needle assembly using an anti-clockwise turning motion as shown in Diagram R.
506 Do konca odvijte sklop injekcijske igle, nasprotno smeri urnega kazalca, kot je prikazano na sliki R.
INFORMATION FOR THE USER
507 NAVODILO ZA UPORABO
IntronA 60 million IU solution for injection, multidose pen Interferon alfa-2b
IntronA 60 milijonov i. e., raztopina za injiciranje, peresnik z večimi odmerki interferon alfa- 2b
 490 Using IntronA with food and drink While being treated with IntronA, your doctor may want you to drink extra fluids to help prevent low blood pressure.
509 Uporaba zdravila IntronA skupaj s hrano in pijačo Medtem, ko prejemate zdravilo IntronA vam bo vaš zdravnik lahko naročil, naj pijete več tekočine, da bi preprečili nizek krvni tlak.
 491 Multiple myeloma:
510 Multipli mielom:
 492 Paediatric Use:
511 Uporaba pri otrocih:
 493 Uncommonly reported side effects (at least 1 in every 1000 patients, but less than 1 in every 100 patients): bacterial infection and feeling of pins and needles.
Občasno opisani neželeni učinki (pri najmanj 1 na vsakih 1. 000 bolnikov, vendar manj kot 1 na vsakih 100 bolnikov): bakterijske okužbe, pojav parastezij.
6.
513 6.
- The active substance is recombinant interferon alfa-2b, 60 million IU/pen
- Zdravilna učinkovina je rekombinantni interferon alfa- 2b, 60 milijonov i. e. / peresnik.
 494 What IntronA looks like and contents of the pack
Izgled zdravila IntronA in vsebina pakiranja
IntronA, 60 million IU/pen, solution for injection:
IntronA, 60 milijonov i. e. / peresnik, raztopina za injiciranje:
Norge Pb.
514 Norge Deutschland Pb.
 495 Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ: + 30-210 98 97 300
Taśmowa 7 Αγίου Δημητρίου 63 PL- 02- 677 Warszawa GR- 174 55 Άλιμος Tel.: + 48 - (0) 22 478 41 50 Tηλ.: + 30- 210 98 97 300
Lietuva Kęstučio g.
515 Lietuva Kęstučio g.
 496 HOW TO SELF INJECT INTRONA
516 KAKO SI LAHKO SAMI INJICIRATE ZDRAVILO INTRONA
- The colour coding strip pink and the push button are at the bottom of the pen as it is held cap
- Rožnat trak za barvno kodiranje jakosti in gumb sta na dnu peresnika, če ga držite tako, da je
 497 Measuring the dose of IntronA Take the pen out of the refrigerator about one-half hour before administering the dose so that the solution in the pen is at room temperature when it is injected.
517 Merjenje odmerka zdravila IntronA Peresnik vzemite iz hladilnika približno pol ure pred injiciranjem, da bo raztopina v njem ob injiciranju na sobni temperaturi.
 498
518
 4 99 Diagram K
519 Slika K
 500 Number of “turns” and
Število “ obratov ” in“ klikov ”
Corresponding doses (million IU) using
Ustrezen odmerek (milijoni i. e.) uporabljenega zdravila IntronA, raztopina za injiciranje, večodmerni peresnik 60 milijonov i. e. / peresnik:
“clicks”
1 polni
10
520
11 clicks
2 polna obrata (10 klikov) 11 klikov 12 klikov 13 klikov 14 klikov
11
10 11 12 13 14
14 clicks
3 polni obrati (15 klikov)
16
16 16 klikov
18 clicks
17 17 klikov
18
18 18 klikov
19
19 19 klikov
4 full turns (20 clicks)*
* 4 polni obrati ustrezajo največjemu odmerku za dajanje v eni injekciji.
*4 full turns correspond to the maximum dose to be administered in one injection.
Presnikje oblikovan tako, da njegovo vsebino 60 milijonov i. e., lahko odmerjamo v razponu od 5 do 20 milijonov i. e.
The pen is designed to deliver its contents of 60 million IU in doses ranging from 5 to 20 million IU.
S peresnikom lahko dajemo največ 12 odmerkov po 5 milijonov i. e., v časovnem obdobju, ki ni daljše kot 4 tedne.
 501 Diagram N
Slika N
 502 Diagram Q
Slika Q
Completely unscrew the injection needle assembly using an anti-clockwise turning motion as shown in Diagram R.
522 Do konca odvijte sklop injekcijske igle, nasprotno smeri urnega kazalca, kot je prikazano na sliki R.
 503
523
If you want more information on the basis of the CHMP recommendations, read the Scientific Discussion (also part of the EPAR).
Če želite več informacij o podlagi za priporočila CHMP preberite znanstveno razpravo (ki je prav tako del EPAR).
What is INVANZ?
Kaj je zdravilo INVANZ?
INVANZ is a vial containing a white powder which is dissolved before use to make up a solution for infusion (drip into a vein).
Zdravilo INVANZ je viala z belim praškom, ki se pred uporabo raztopi, da nastane raztopina za infundiranje (dajanje tekočine v veno).
INVANZ contains the active substance ertapenem.
Zdravilo INVANZ vsebuje zdravilno učinkovino ertapenem.
What is INVANZ used for?
Za kaj se zdravilo INVANZ uporablja?
INVANZ is an antibiotic.
Zdravilo INVANZ je antibiotik.
It is used to treat infections such as infections of the abdomen, community- acquired pneumonia (infection of the lungs – community-acquired means that when the infection has been caught outside of hospital), gynaecological infections, and foot infections in diabetic patients.
Uporablja se za zdravljenje okužb, kot so okužbe trebuha, izvenbolnišnično pridobljena pljučnica (okužba pljuč – izvenbolnišnično pridobljena pomeni, da se okužite izven bolnišnice), ginekološke okužbe in okužbe stopala pri bolnikih s sladkorno boleznijo.
INVANZ can be used in adults and children (from the age of 3 months).
Zdravilo INVANZ se lahko uporablja za odrasle in otroke (starejše od 3 mesecev).
INVANZ is used when the bacteria (germs) that cause these infections are likely to be killed by the antibiotic.
Zdravilo INVANZ se uporabi, če je verjetno, da bo uničilo bakterije (klice), ki povzročajo okužbo.
Before using INVANZ, doctors need to look at any official guidance they may have on the appropriate use of antibiotics.
Pred uporabo zdravila INVANZ morajo zdravniki preveriti uradne smernice glede pravilne uporabe antibiotikov.
How is INVANZ used?
Kako se zdravilo INVANZ uporablja?
When given to adults and adolescents, INVANZ is given as 1 gram once a day.
Odmerek zdravila INVANZ za odrasle bolnike in mladostnike je 1 gram dnevno.
For younger patients (3 months to 12 years), it is given twice a day, and the dosage is based on the weight of the patient (15 mg/ kg bodyweight).
Pri mlajših bolnikih (starih 3 mesece do 12 let) se zdravilo daje dvakrat dnevno, odmerek pa je odvisen od telesne mase bolnika (15 mg/ kg telesne mase).
The treatment lasts between 3 and 14 days, depending on the type and the severity of the infection.
Zdravljenje traja od 3 do 14 dni, odvisno od vrste okužbe in njene resnosti.
Once the infection has improved, the patient’ s treatment can be switched to an oral antibiotic.
Ko se stanje okužbe izboljša, lahko bolnik začne jemati peroralni antibiotik.
Patients with severe renal problems, including those on dialysis, should not be given INVANZ.
Bolniki s hudimi težavami z ledvicami, vključno z bolniki na dializi, ne smejo dobiti zdravila INVANZ.
How does INVANZ work?
Kako zdravilo INVANZ deluje?
The active substance in INVANZ, ertapenem, is an antibiotic belonging to the group of the ‘ carbapenems’.
Zdravilna učinkovina zdravila INVANZ je ertapenem, ki je antibiotik iz skupine „ karbapenemov “.
It acts by binding to some proteins on the surface of the cells of the bacteria.
Deluje z vezavo na nekatere beljakovine na površini bakterijskih celic.
This upsets the essential functions that keep the cell alive, and kills the bacteria.
S tem prekine ključne funkcije, ki ohranjajo celico živo, in bakterijo ubije.
The list of bacteria against which INVANZ is active can be found in the Summary of Product Characteristics.
Seznam bakterij, proti katerim zdravilo INVANZ učinkuje, najdete v Povzetku glavnih značilnosti zdravila.
How has INVANZ been studied?
Kako je bilo zdravilo INVANZ raziskano?
The effects of INVANZ were first tested in experimental models before being studied in humans.
Učinki zdravila INVANZ so bili najprej preizkušeni s pomočjo izkustvenih modelov, nato pa so jih raziskali pri ljudeh.
The use of INVANZ in the treatment of infections in adults was compared to that of other antibiotics: it was compared with ceftriaxone in community-acquired pneumonia (CAP; 866 patients) and urinary tract infections (592 patients), and with a combination of piperacillin and tazobactam in abdominal 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Zdravilo INVANZ za zdravljenje okužb pri odraslih so primerjali z drugimi antibiotiki; primerjali so ga s ceftriaksonom za izvenbolnišnično pridobljeno pljučnico (866 bolnikov) in okužbe urinskih poti 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
(44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. eu. int http: / /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged infections (655 patients), gynaecological infections (412 patients) and skin and soft tissues infections (infections of the skin and the tissues just below the skin, 540 patients, and diabetic foot infections; 576 patients).
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. eu. int http: // www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged (592 bolnikov) ter s kombinacijo piperacilina in tazobaktama za okužbe trebuha (655 bolnikov), ginekološke okužbe (412 bolnikov) in okužbe kože ter mehkih tkiv (okužbe kože ter tkiv tik pod kožo, 540 bolnikov; okužbe diabetičnega stopala, 576 bolnikov).
The studies in children were in the same types of infections, and the comparators were ceftriaxone (CAP; 389 children) and ticarcillin/ clavulanate (intra-abdominal infections; 105 children).
Zdravilo INVANZ je bilo primerjano s ceftriaksonom (izvenbolnišnično pridobljena pljučnica; 389 otrok) in tikarcilinom/ klavulanatom (okužbe v trebuhu; 105 otrok).
The studies generally examined if the infection was cured in the days following treatment (Test of Cure – 7 to 28 days after treatment depending on the type of infection).
V raziskavah so na splošno preverjali, če je se je okužba pozdravila v dnevih po zdravljenju (preskus ozdravitve – 7 do 28 dni po zdravljenju, odvisno od vrste okužbe).
What benefit has INVANZ shown during the studies?
Kakšne koristi je zdravilo INVANZ izkazalo med raziskavami?
INVANZ was as effective as ceftriaxone or piperacillin/ tazobactam in abdominal infections, community-acquired pneumonia, gynaecological infections and diabetic foot infections: the same cure rates were reached for both INVANZ and the comparator medicine (between 87 and 94% for INVANZ, against 83 to 92% for the comparators).
Zdravilo INVANZ je bilo enako učinkovito kot ceftriakson ali piperacilin/ tazobaktam za trebušne okužbe, izvenbolnišnično pridobljeno pljučnico, ginekološke okužbe in okužbe diabetičnega stopala: zdravilo INVANZ in primerjana zdravila so imeli enake stopnje ozdravitve (med 87 in 94% za zdravilo INVANZ in med 83 do 92% za primerjana zdravila).